ATLANTA - A federal advisory panel on Thursday endorsed two new combination vaccines designed to reduce the number of needle sticks that young children must endure to get the recommended immunizations.
The panel gave its nod to a four-in-one shot made by GlaxoSmithKline. It offers protection against diphtheria, tetanus, pertussis and polio and costs $45. It's given once to preschool-aged children.